The role of immune infiltrates as prognostic biomarkers in patients with breast cancer

被引:44
作者
Baxevanis, Constantin N. [1 ]
Sofopoulos, Michael [2 ]
Fortis, Sotirios P. [1 ]
Perez, Sonia A. [1 ]
机构
[1] St Savas Canc Hosp, Canc Immunol & Immunotherapy Ctr, 171 Alexandras Ave, Athens 11522, Greece
[2] St Savas Canc Hosp, Pathol Dept, Athens, Greece
关键词
Breast cancer; TILs; CD163+cells; CD8+T cells; Biomarkers; TIMO XIV; REGULATORY T-CELLS; NEOADJUVANT CHEMOTHERAPY; TUMOR; LYMPHOCYTES; IMMUNOSURVEILLANCE; IDENTIFICATION; IMMUNOTHERAPY; MACROPHAGES; RESISTANCE; ADJUVANT;
D O I
10.1007/s00262-019-02327-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The presence of immune infiltrates in the tumor microenvironment has been documented in many types of cancer. Moreover, the preexistent or endogenous immunity which consists of interactions between intratumoral lymphocytes and tumor cells is mostly relevant for the successful application of various anticancer therapies, including standard chemotherapy, immune checkpoint inhibition-based immunotherapy and targeted therapies. The immunoscore defines densities of intratumoral immune infiltrates which determine poor or favorable prognosis depending on their quantity and quality in the tumor compartments. Results from large clinical studies have demonstrated an association between high densities of cytotoxic and memory TILs in the tumor compartments with improved prognosis. Importantly, we have demonstrated that differential combined densities of immune infiltrates jointly analyzed in the tumor center (TC) and the invasive margin (IM) have a significant prognostic value in breast cancer patients with poor clinicopathological parameters.
引用
收藏
页码:1671 / 1680
页数:10
相关论文
共 64 条
[1]   Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer [J].
Asano, Y. ;
Kashiwagi, S. ;
Goto, W. ;
Kurata, K. ;
Noda, S. ;
Takashima, T. ;
Onoda, N. ;
Tanaka, S. ;
Ohsawa, M. ;
Hirakawa, K. .
BRITISH JOURNAL OF SURGERY, 2016, 103 (07) :845-854
[2]   Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State [J].
Baxevanis, Constantin N. ;
Perez, Sonia A. .
VACCINES, 2015, 3 (03) :597-619
[3]   The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[4]   Natural immunity to cancer in humans [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Fridman, Wolf-Herman ;
Pages, Franck ;
Galon, Jerome .
CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (02) :215-222
[5]   Classical pathology and mutational load of breast cancer - integration of two worlds [J].
Budczies, Jan ;
Bockmayr, Michael ;
Denkert, Carsten ;
Klauschen, Frederick ;
Lennerz, Jochen K. ;
Gyorffy, Balazs ;
Dietel, Manfred ;
Loibl, Sibylle ;
Weichert, Wilko ;
Stenzinger, Albrecht .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2015, 1 (04) :225-238
[6]   Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients [J].
Chan, Monica S. M. ;
Wang, Lin ;
Felizola, Saulo J. A. ;
Ueno, Takayuki ;
Toi, Masakazu ;
Loo, W. ;
Chow, Louis W. C. ;
Suzuki, Takashi ;
Sasano, Hironobu .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (04) :E295-E304
[7]   Regulation of CTL Infiltration Within the Tumor Microenvironment [J].
Church, Sarah E. ;
Galon, Jerome .
TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 :33-49
[8]   The molecular profile of luminal B breast cancer [J].
Creighton, Chad J. .
BIOLOGICS-TARGETS & THERAPY, 2012, 6 :289-297
[9]   The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature [J].
deLeeuw, Ronald J. ;
Kost, Sara E. ;
Kakal, Juzer A. ;
Nelson, Brad H. .
CLINICAL CANCER RESEARCH, 2012, 18 (11) :3022-3029
[10]   Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group [J].
Denkert, Carsten ;
Wienert, Stephan ;
Poterie, Audrey ;
Loibl, Sibylle ;
Budczies, Jan ;
Badve, Sunil ;
Bago-Horvath, Zsuzsanna ;
Bane, Anita ;
Bedri, Shahinaz ;
Brock, Jane ;
Chmielik, Ewa ;
Christgen, Matthias ;
Colpaert, Cecile ;
Demaria, Sandra ;
Van den Eynden, Gert ;
Floris, Giuseppe ;
Fox, Stephen B. ;
Gao, Dongxia ;
Heppner, Barbara Ingold ;
Kim, S. Rim ;
Kos, Zuzana ;
Kreipe, Hans H. ;
Lakhani, Sunil R. ;
Penault-Llorca, Frederique ;
Pruneri, Giancarlo ;
Radosevic-Robin, Nina ;
Rimm, David L. ;
Schnitt, Stuart J. ;
Sinn, Bruno V. ;
Sinn, Peter ;
Sirtaine, Nicolas ;
O'Toole, Sandra A. ;
Viale, Giuseppe ;
Van de Vijver, Koen ;
de Wind, Roland ;
von Minckwitz, Gunter ;
Klauschen, Frederick ;
Untch, Michael ;
Fasching, Peter A. ;
Reimer, Toralf ;
Willard-Gallo, Karen ;
Michiels, Stefan ;
Loi, Sherene ;
Salgado, Roberto .
MODERN PATHOLOGY, 2016, 29 (10) :1155-1164